This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Oct;364(9444):1466-7.

doi: 10.1016/S0140-6736(04)17287-5.

Drug-eluting stents: some bare facts

Mark J Eisenberg¹

Affiliations

PMID: 15500872
DOI: 10.1016/S0140-6736(04)17287-5

Comment

Drug-eluting stents: some bare facts

Mark J Eisenberg. Lancet. 2004 Oct.

. 2004 Oct;364(9444):1466-7.

doi: 10.1016/S0140-6736(04)17287-5.

Author

Mark J Eisenberg¹

Affiliation

¹ Division of Cardiology & Clinical Epidemiology, Jewish General Hospital, Montreal, Quebec, Canada, H3T 1EZ. marke@epid.jgh.mcgill.ca

PMID: 15500872
DOI: 10.1016/S0140-6736(04)17287-5

No abstract available

PubMed Disclaimer

Comment on

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.
McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW. McFadden EP, et al. Lancet. 2004 Oct 23-29;364(9444):1519-21. doi: 10.1016/S0140-6736(04)17275-9. Lancet. 2004. PMID: 15500897

Similar articles

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.
McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW. McFadden EP, et al. Lancet. 2004 Oct 23-29;364(9444):1519-21. doi: 10.1016/S0140-6736(04)17275-9. Lancet. 2004. PMID: 15500897
Stent thrombosis in randomized clinical trials of drug-eluting stents.
Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Mauri L, et al. N Engl J Med. 2007 Mar 8;356(10):1020-9. doi: 10.1056/NEJMoa067731. Epub 2007 Feb 12. N Engl J Med. 2007. PMID: 17296821
Late stent thrombosis: a not negligible issue after drug-eluting stent implantation.
Gao RL. Gao RL. Chin Med J (Engl). 2007 Apr 5;120(7):531-2. Chin Med J (Engl). 2007. PMID: 17442197 No abstract available.
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL. Bavry AA, et al. J Am Coll Cardiol. 2005 Mar 15;45(6):941-6. doi: 10.1016/j.jacc.2004.11.064. J Am Coll Cardiol. 2005. PMID: 15766833 Review.
Thrombosis after implantation of drug-eluting stents.
Iakovou I, Mehran R, Dangas G. Iakovou I, et al. Hellenic J Cardiol. 2006 Jan-Feb;47(1):31-8. Hellenic J Cardiol. 2006. PMID: 16532714 Review. No abstract available.

See all similar articles

Cited by

External adjustment sensitivity analysis for unmeasured confounding: an application to coronary stent outcomes, Pennsylvania 2004-2008.
Huesch MD. Huesch MD. Health Serv Res. 2013 Jun;48(3):1191-214. doi: 10.1111/1475-6773.12013. Epub 2012 Dec 3. Health Serv Res. 2013. PMID: 23206261 Free PMC article.
Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature.
Carlsson J, von Wagenheim B, Linder R, Anwari TM, Qvist J, Petersson I, Magounakis T, Lagerqvist B. Carlsson J, et al. Clin Res Cardiol. 2007 Feb;96(2):86-93. doi: 10.1007/s00392-007-0464-x. Epub 2006 Dec 22. Clin Res Cardiol. 2007. PMID: 17180577 Review.
Cost effectiveness of drug-eluting stents in Belgian practice: healthcare payer perspective.
Neyt M, De Laet C, De Ridder A, Van Brabandt H. Neyt M, et al. Pharmacoeconomics. 2009;27(4):313-27. doi: 10.2165/00019053-200927040-00004. Pharmacoeconomics. 2009. PMID: 19485427
Intractable intraoperative bleeding requiring platelet transfusion during emergent cholecystectomy in a patient with dual antiplatelet therapy after drug-eluting coronary stent implantation (with video).
Fujikawa T, Noda T, Tada S, Tanaka A. Fujikawa T, et al. BMJ Case Rep. 2013 Mar 26;2013:bcr2013008948. doi: 10.1136/bcr-2013-008948. BMJ Case Rep. 2013. PMID: 23536626 Free PMC article.
Sirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells.
Zhu S, Viswambharan H, Gajanayake T, Ming XF, Yang Z. Zhu S, et al. BMC Cardiovasc Disord. 2005 Jul 15;5:22. doi: 10.1186/1471-2261-5-22. BMC Cardiovasc Disord. 2005. PMID: 16018822 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information